Publication Name	世界华人消化杂志
手稿编号	39565
手稿来源省、自治区或特别行政区	辽宁省

Received	2023-07-20 00:54
Peer-Review Started	2023-07-20 01:03
To Make the First Decision
Return for Revision	2023-08-03 21:57
修回稿	2023-08-07 08:52
Second Decision	2023-08-16 13:29
期刊总编辑接受
公司总编辑接受	2023-08-16 21:29
预出版	2023-08-16 21:29
缴纳版面费
Edit the Manuscript by Language Editor
排版	2023-08-28 08:29
在线出版	2023-08-28 12:22

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化内科学
手稿栏目类型	述评
文章标题	他汀类药物治疗脂肪性肝病的研究进展
手稿来源	约稿
所有作者列表	方晓慧, 王彩娥, 邓娇, 祁兴顺
基金项目及其编号
通讯作者	祁兴顺, 博士, 副教授, 副主任医师, 110840, 辽宁省沈阳市文化路83号, 北部战区总医院消化内科. xingshunqi@126.com
关键词	脂肪性肝病; 他汀类药物; 治疗; 研究进展
核心内容提要	脂肪性肝病已成为我国第一大慢性肝病, 但目前尚无批准治疗该病的药物. 他汀类药物为临床常用降脂药, 兼具抗炎、抗氧化、抗纤维化作用, 可对该病发挥一定疗效. 本文旨在回顾并分析不同他汀类药物对脂肪性肝病的疗效.
出版日期	2023-08-28 12:22
引文著录	方晓慧, 王彩娥, 邓娇, 祁兴顺. 他汀类药物治疗脂肪性肝病的研究进展. 世界华人消化杂志 2023; 31(16): 659-665
URL	https://www.wjgnet.com/1009-3079/full/v31/i16/659.htm
DOI	https://dx.doi.org/10.11569/wcjd.v31.i16.659

Full Article (PDF)	WCJD-31-659-with-cover.pdf
审稿意见	WCJD-39565-Peer-review(s).pdf
科学编辑工作清单	WCJD-39565-Scientific editor work list.pdf